Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Perspective of Cell-Free DNA Testing for Fetal Aneuploidies

1 Jan 2014

Abstract excerpt

Cell-free DNA testing in maternal blood provides the most effective method of screening for trisomy 21, with a reported detection rate of 99% and a false positive rate of less than 0.1%. After many years of research, this method is now commercially available and is carried out in an increasing number of patients, and there is an expanding number of conditions that can be screened for. However, the application of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24931002
DOI: 10.1159/000362940

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Perspective of Cell-Free DNA Testing for Fetal AneuploidiesPMID 24931002Read ↗

Non-Invasive Prenatal Testing: Current Perspectives and Future ChallengesSemantic proximity Read ↗

Clinical implementation of NIPT – technical and biological challengesSemantic proximity Read ↗

What does next-generation sequencing mean for prenatal diagnosis?Semantic proximity Read ↗

Combined First Trimester Screening and Cell-Free Fetal DNA – “Next Generation Screening”Semantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

Cell-Free DNA ScreeningSemantic proximity Read ↗

Aneuploidy Screening in PregnancySemantic proximity Read ↗

Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis of Chromosomopathies and Pediatric Monogenic Diseases: A Critical Appraisal and Medicolegal RemarksSemantic proximity Read ↗

Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US contextSemantic proximity Read ↗

[Cell-free nucleic acid-based non-invasive prenatal diagnosis of fetal aneuploidies].Semantic proximity Read ↗

Analysis of cell‐free <scp>DNA</scp> in maternal blood in screening for fetal aneuploidies: updated meta‐analysisSemantic proximity Read ↗

Cell-free DNA screening for fetal aneuploidy as a clinical serviceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.